CSRHub Research

CSRHub Research

Periodically, CSRHub publishes new research regarding sustainability and corporate social responsibility. Most of the research is conducted by CSRHub Co-fouder and CEO, Bahar Gidwani and many times, in collaboration with industry leading partners.

Content from this campaign

Real Time ESG Tracking From StockSnips
The researchers at StockSnips have been transforming unstructured data into financial sentiment insights for several years. Their AI / ML (Artificial Intelligence / Machine Learning) based system reads thousands of articles and tags the relevant snippets to derive a quantified investor sentiment measure that could drive stock performance. StockSnips has now developed an ESG (Environment,...
Sep 23, 2021 12:00 PM ET
Pfizer Versus Moderna Versus Johnson & Johnson
As previously seen on Skytop and published with permission. Many of us have recently pondered the question: which vaccine is better—Pfizer, Moderna, or J&J? Those of us interested in sustainability may also want to know which of these companies has the best ESG (...
Sep 22, 2021 4:15 PM ET
Does AA1000 Assurance Have an Effect on Perceived Sustainability Performance?
Many companies spend time and money trying to make sure that the ESG data they report has been properly collected and communicated. One system that supports this is the AA1000 Assurance standard. ...
Sep 21, 2021 1:00 PM ET
CSRHub's Data Used in ecountabl, a New Socially Responsible Consumer App
We are excited to be part of the newest responsible consumer technology by ecountabl Inc. ecountabl's platform simplifies consumer decision-making and encourages more socially responsible choices. With the abundance of brand options today, the decision to purchase from a specific company not only reflects a product need but is a...
Aug 19, 2021 11:50 AM ET
Pfizer Vs Moderna Vs Johnson & Johnson
Those interested in sustainability should be interested in a different way of comparing the major vaccines. Vaccine-producing companies have made huge contributions to fighting the COVID plague. They have spent millions of dollars developing and manufacturing products that have only moderate financial benefit, but deliver big social value. Working with ...
Jun 29, 2021 2:00 PM ET


  • 2
  • 3
  • 4
  • 5